Medical
NEW
WT1 Immunotherapy for Mesothelioma: The #1-Ranked Cancer Target With 0 Approved Treatments in 2026
David Foster
June 8, 2026
WT1 is the #1-ranked cancer immunotherapy target, but no WT1 treatment is approved for mesothelioma. The galinpepimut-S vaccine, the trials, and 2026 options.
11 min read 6 FAQs
Read